Coherus Oncology, Inc. · NASDAQ:CHRS
The Vanguard Group reported a 8.29% stake in Coherus Oncology, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 8.29% stake in Coherus Oncology, Inc., 10,028,893 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 8.29%
- Shares
- 10,028,893
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 8.29% | 10,028,893 |
Source
Related
- Coherus Oncology, Inc.
- The Vanguard Group
- Coherus Oncology, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Satvat Ali J. · Jun 9, 2026
- Form 4 · Karachun Rita A · Jun 9, 2026
- Form 4 · Newcomer Lee Nisley · Jun 9, 2026
- Form 4 · Ryan Michael Lee · Jun 9, 2026